CASTLE BIOSCIENCES INC (CSTL) › Cash & EquivalentsCASTLE BIOSCIENCES INC (CSTL) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2018: $4.48M2019: $98.84M2020: $409.85M2021: $329.63M2022: $122.95M2023: $98.84M2024: $119.71M2025: $116.73M$116.73M2018Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$116.73M-2.5%2024$119.71M+21.1%2023$98.84M-19.6%2022$122.95M-62.7%2021$329.63M-19.6%2020$409.85M+314.6%2019$98.84M+2106.9%2018$4.48M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share